Skip to main content

CRL

Stock
Health Care
Diagnostics & Research

Performance overview

CRL Price
Price Chart

Forward-looking statistics

Beta
1.19
Risk
37.17%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

charles river provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. #drugdiscovery #biotech #biotechnology #pharmaceuticals #cro

Company info

SectorHealth Care
IndustryDiagnostics & Research
Employees17K
Market cap$11.1B

Fundamentals

Enterprise value$10.3B
Revenue$4.0B
Revenue per employee—
Profit margin-0.49%
Debt to equity92.21

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)-$0.61
Dividend per share$1.20
Revenue per share$78.58
Avg trading volume (30 day)$128M
Avg trading volume (10 day)$140M
Put-call ratio—

Macro factor sensitivity

Growth+1.3
Credit+3.3
Liquidity-0.0
Inflation-2.0
Commodities+0.4
Interest Rates-1.9

Valuation

Dividend yield0.76%
PEG Ratio15.28
Price to sales1.92
P/E Ratio15.28
Enterprise Value to Revenue2.55
Price to book2.42

Upcoming events

Next earnings dayMay 7, 2025
Next dividend day—
Ex. dividend dayNovember 28, 1996

News

Why Is Charles River (CRL) Down 0.1% Since Last Earnings Report?

Charles River (CRL) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research (June 6, 2025)
Activist Elliott reaches key agreement with Charles River. Here are three ways to create value

The firm has three possible paths toward value creation at the drug development company.

CNBC (May 10, 2025)
Charles River Laboratories' Q1 Earnings Beat Consensus, Stock Trades Higher On Signs Of Demand Stabilization

Charles River Laboratories International Inc CRL stock is trading higher on Wednesday after the company released better than expected first-quarter 2025 earnings.

Benzinga (May 7, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free